Why Publish in IJPPR?

As an author, you want your work to have the most effect and to be as widely accessible as possible. Since 2010, IJPPR has provided:

• Open Access for reading, educating, and applying from the time of publication, your study in the IJPPR is freely available to Before accessing our content, readers do not need to subscribe, pay a one-time price, or register. Educators, students, physicians, researchers, patients, and policymakers from all around the globe can access and utilize our materials for free. Others can use your data to enhance field research and increase the impact of your effort.
• Fast and professional peer review IJPPR is managed by a group of expert editors with years of expertise. To offer writers with a quick, fair, and helpful review process, we collaborate closely with academic editors and peer reviewers.
• Time-saving pre-submission inquiries Prior to official submission, authors submit a pre- submission enquiry that includes a referenced abstract and a cover letter. This approach allows us to tell you whether the work is possibly appropriate within 48 hours, in which case we invite you to submit the entire
• Rapid publication It takes around 4 weeks from acceptance to
• Editors' summaries IJPPR is great for accurate media coverage, patient education, and student and other non-physician learning because professional editors set your work in context and explain methodology, results, and consequences in accessible language that non-specialists can comprehend.
• Publicity We send out weekly press releases on papers published by IJPPR in order to guarantee that articles are covered appropriately by the media. We also promote stories on Twitter and other social media platforms in order to raise awareness and stimulate
• Abstract translations Provide translations of your abstract, which will be published with the article and made freely available to readers and search engines, allowing you to reach a wider audience.
• No pharmaceutical or device company ads IJPPR does not accept advertising from pharmaceutical or device firms, ensuring that readers do not come across advertising from firms with competing interests while reading your work and avoiding potential conflicts of interest in editorial
• Commentary by authors without financial conflicts of interest IJPPR offers expert analysis that is free of financial conflicts of interest, giving it an authoritative voice that is not influenced by commercial marketing or
• Publication decisions not driven by impact factor IJPPR offers you with article-level analytics to assist you evaluate the effect of your content. Decisions to publish are made based on the research and the article's potential impact on patients and policy, not on whether the paper will have an impact on the journal's impact
• No arbitrary constraints on article length or presentation Your research paper should include all of the methodologies used to clearly describe what was done as well as all of the outcomes, all of which should be available from wherever the piece is visited. The length of an article in the IJPPR is governed by the science rather than an imposed page
• Post-publication Commenting allows readers and writers to have a direct conversation right from the full-text
• Linkage to the full IJPPR suite of Open Access publications At your request, papers submitted to IJPPR that are determined to be better suited to another IJPPR publication can be moved